Astaxanthin
SupplementThe medical score is 12 points below the community score. Clinically, effect sizes in RCTs are mostly small and studies are methodologically limited [s5, s6], whereas forum users subjectively report more pronounced improvements in eye fatigue and skin [c1, c3, c4]. This may be attributable to placebo effects, individual variability, or publication bias in community reporting.
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
Astaxanthin is a structurally unique carotenoid capable of neutralizing both lipophilic and hydrophilic radicals — a mechanistic edge over most antioxidants. Clinical evidence is moderate (Medical Score 50/100): eye fatigue and photoprotection show the most consistent signals, while sports performance and systemic inflammation remain inconclusive. The EFSA considers 8 mg/day safe; some community users self-dose above 20 mg without medical supervision, which is concerning given highly variable product quality on the market. One hard rule: synthetic astaxanthin is not approved for human consumption — only use Haematococcus pluvialis-derived extracts.
Description
Natural carotenoid from microalgae with potent antioxidant and anti-inflammatory activity; used for skin protection, eye health, and sports performance [s1, s2].
Astaxanthin (ASX) is a xanthophyll carotenoid occurring naturally in the microalga Haematococcus pluvialis, in salmon, shrimp, and other seafood. It is responsible for the reddish coloration of these organisms. As a lipid-soluble antioxidant, astaxanthin demonstrates considerably greater radical-scavenging activity in vitro than other carotenoids such as beta-carotene or lycopene [s1, s3]. Unlike beta-carotene, astaxanthin is not converted to vitamin A in the body, and toxic accumulation has not been reported even at higher doses [s10]. Astaxanthin can cross the blood-brain barrier and the blood-retinal barrier, enabling effects on the eyes and brain [s4, s7]. Clinical studies (mostly small RCTs) support effects on skin aging, eye fatigue, inflammatory markers, and endurance performance. Meta-analyses demonstrate effects on oxidative stress markers, HDL cholesterol, and skin quality, though overall with small effect sizes and methodological limitations [s5, s6, s8]. Bioavailability is markedly improved by lipid-based formulations and concurrent fat intake [s11]. The body of evidence is assessed as insufficient for definitive recommendations by institutions such as medizin-transparent.at and the Verbraucherzentrale [s2, s15].
Legal Status (DE)
In Germany and the EU, astaxanthin is authorized as a novel food (EU Implementing Regulation 2017/2470). Astaxanthin-rich oleoresin from Haematococcus pluvialis is marketable as a food supplement. The EFSA has established 8 mg/day as a safe daily intake for adults [s12, s13]. In Switzerland, removal from Annex 1 Part B of the VNem was planned, as it is classified as a novel food under the EU Union list [s14].
Mechanism of Action
Astaxanthin possesses a unique chemical structure with 13 conjugated double bonds in the central nonpolar region and hydroxyl and keto groups on both terminal rings. This structure enables the molecule to span both the inner and outer layers of the cell membrane, scavenging both lipophilic and hydrophilic free radicals [s1, s3]. Primary mechanisms of action [s1, s3, s4, s7]: 1. Antioxidant activity: Direct neutralization of reactive oxygen species (ROS) and singlet oxygen. In vitro, ASX exhibits an ED50 of approximately 200 nM in radical-scavenging assays — markedly lower than other carotenoids (200–1000 nM) [s1]. 2. Anti-inflammatory activity: Inhibition of the NF-κB signaling pathway, reducing production of pro-inflammatory cytokines such as TNF-α and IL-6 [s9]. 3. Mitochondrial protection: Enhancement of mitochondrial function and fatty acid beta-oxidation, potentially relevant to endurance performance. 4. Eye-specific effects: Relaxation of the ciliary muscle, improvement of retinal capillary blood flow, and inhibition of NF-κB in the ciliary body [s7]. 5. Skin protection: Inhibition of matrix metalloproteinases (e.g., MMP-1) responsible for UV-induced collagen degradation; reduction of melanin synthesis and hyperpigmentation [s5]. 6. Lipid metabolism: A meta-analysis of 13 clinical studies (n=450) demonstrated an increase in HDL cholesterol [s6].
Dosing
Männliche Fertilität
- Dose
- 16 mg/day
- Frequency
- 1× täglich
- Route
- oral
- Duration
- Mindestens 8–12 Wochen (ein Spermatogenese-Zyklus)
- Timing
- Based on Comhaire et al. 2005 (n = 30, 16 mg/day astaxanthin). Only one RCT available; recommendation to be made with caution. Combination with standard therapy; not established as monotherapy.
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Magen-Darm-Beschwerden (Übelkeit, weicher Stuhl, Bauchkrämpfe) Occasionally described in Reddit reports and clinical studies; more frequent at higher doses and on an empty stomach [s10, c2]. | gelegentlich | leicht |
| Orangefärbung des Stuhls Due to the carotenoid nature of astaxanthin, stool may become reddish-orange in color; harmless and reversible [s15]. | gelegentlich | leicht |
| Leichte Orangefärbung der Haut (Karotinodermie) bei sehr hohen Dosen At very high doses (exceeding study doses), a mild orange tint of the skin has been described; reversible upon discontinuation [s15]. | selten | leicht |
| Beeinflussung von Leberenzymen Effects on liver enzymes have been observed in studies; this may influence the metabolism of certain medications [s2]. | selten | moderat |
| Hormonelle Effekte (5-alpha-Reduktase-Hemmung) Astaxanthin inhibits 5-alpha-reductase in vitro; clinical relevance at normal dosing is unclear [s10]. | theoretisch | leicht |
Contraindications
Insufficient safety data available for pregnant and breastfeeding women. Use is not recommended [s10, s15].
Astaxanthin is commonly derived from shellfish or microalgae; cross-reactions are possible in individuals with known allergies [s15].
Astaxanthin may potentially affect blood coagulation; caution with concomitant use of anticoagulants [s10].
Theoretical 5-alpha-reductase inhibition; clinical consequences in hormone-dependent conditions unclear [s10].
Interactions
Synergistic
Astaxanthin and omega-3 fatty acids (EPA/DHA) act synergistically, as Astaxanthin, a lipophilic antioxidant, inhibits the oxidative degradation of highly unsaturated fatty acids in cell membranes and lipoproteins. Additionally, both substances can jointly suppress pro-inflammatory signaling pathways (including NF-κB, eicosanoid synthesis), resulting in an enhanced overall anti-inflammatory effect.
Astaxanthin and CoQ10 may provide complementary antioxidant protection. Ubiquinol promotes mitochondrial energy production, while Astaxanthin protects mitochondria from oxidative stress. The combination appears safe, although synergistic benefit was limited in some studies.
Co-administration of astaxanthin and curcumin demonstrated synergistic effects on lipid metabolism, inflammatory markers, and hormonal functions in animal studies. Both inhibit inflammatory signaling pathways and exert antioxidant effects via complementary mechanisms.
Alpha-lipoic acid is both water- and fat-soluble and can regenerate other antioxidants. In combination with membrane-associated astaxanthin, comprehensive protection across different cellular compartments is achieved. A synergistic effect on cellular protection against free radicals is under discussion.
Studies
Tier B — Moderate Evidence
Community Evidence
Top reported benefits
- Improvement of eye fatigue / dry eyes (frequently reported)
- Gradual improvement in skin quality after several weeks of use
- Subjectively increased energy levels and mental clarity
- Positive effects on joints and muscle recovery after exercise
- Better sun tolerance / reduced sunburn
Top reported issues
- Gastrointestinal complaints (diarrhea, cramps) in some users
- No noticeable effect in a subset of users
- Slow onset of action (often only after 4–8 weeks)
- Orange discoloration of stool perceived as alarming (harmless)
Several users report that effects are subtle and difficult to assess objectively. In German forums, critical users consider the evidence base insufficient. Some users take very high doses (>20 mg/day) without medical supervision. Quality of commercial products varies considerably; synthetic astaxanthin is not approved for human use [c3, c4].
Scientific Sources
- Effects of Astaxanthin Supplementation on Fatigue, Motor Function and Cognition: A Meta-Analysis of Randomized Controlled Trials
Liu C, Dong X, Jia J, Ha M (2024). Food & Function (SAGE)BDOI - The Role of Astaxanthin as an Antioxidant and Anti-Inflammatory Agent in Human Health: A Systematic Review
Multiple authors (MDPI) (2026). International Journal of Molecular SciencesBLink - Therapeutic uses of natural astaxanthin: An evidence-based review focused on human clinical trials
Brendler T, Williamson EM, et al. (2021). Pharmacological ResearchBDOI - Astaxanthin: How much is too much? A safety review
Davinelli S, Nielsen ME, Scapagnini G (2018). NutrientsBPMID:31788888DOI - Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations
Odeberg JM, Lignell A, Pettersson A, et al. (2003). European Journal of Pharmaceutics and BiopharmaceuticsBPMID:12885395DOI - Safety of astaxanthin for its use as a novel food in food supplements
EFSA NDA Panel (2020). EFSA Journal / PMCADOI - Safety of the extension of use of oleoresin from Haematococcus pluvialis containing astaxanthin as a novel food pursuant to Regulation (EU) 2015/2283
EFSA NDA Panel (2025). EFSA JournalADOI - Verordnung des EDI über Nahrungsergänzungsmittel (VNem) – Anhang 1 Astaxanthin
Eidgenössisches Departement des Innern (EDI) (2022). Bundesamt für Lebensmittelsicherheit und Veterinärwesen (BLV)ALink - Astaxanthin für den guten Durchblick? – Nahrungsergänzungsmittel
Verbraucherzentrale Redaktion (2023). Verbraucherzentrale.deBLink - Astaxanthin supplementation mildly reduced oxidative stress and inflammation biomarkers: a systematic review and meta-analysis of randomized controlled trials
["Zhou X"] (2021). Nutrition ResearchAPMID:30982442DOI - Effects of 4-week astaxanthin supplementation on athletic performance and body composition in young male taekwondo athletes: a randomized, double-blind, placebo-controlled trial
["Zhang XC","Shu MY","Li KM","Wang N","Wang XY","Shao L","Yang Y","Liu W","Zhu S","Zuo L","Li GQ","Chen XH","Liang J","Kim CH"] (2025). Frontiers in NutritionBDOI - Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects—a randomized, single-dose, cross-over trial
["Köhler A","Sarkkinen E","Tapola N","Niskanen T","Bruheim I"] (2015). Lipids in Health and DiseaseBPMID:25884846DOI - Combined conventional/antioxidant 'Astaxanthin' treatment for male infertility: a double blind, randomized trial
["Comhaire FH","El Garem Y","Mahmoud A","Eertmans F","Schoonjans F"] (2005). Asian Journal of AndrologyBPMID:16110353DOI - Astaxanthin: Wirkung, Risiken und wann Vorsicht geboten ist
Apotheken Umschau Redaktion (2023). Apotheken UmschauBLink - Biological and neurological activities of astaxanthin (Review)
Li J, Xia Y, Liu T, et al. (2022). Molecular Medicine ReportsBDOI - The Role of Astaxanthin as a Nutraceutical in Health and Age-Related Conditions
Ambati RR, Phang SM, Ravi S, et al. (2022). Nutrients / PMCBLink - Systematic Review and Meta-Analysis on the Effects of Astaxanthin on Human Skin Ageing
Tominaga K, Hongo N, Karato M, et al. (2021). NutrientsAPMID:34578794DOI - Die Carotinoide Astaxanthin, Lycopin, Zeaxanthin und Lutein (Metaanalysen-Zusammenfassung)
Hopkins Formulations Redaktion (2023). Hopkins Formulations BlogBLink - Clinical Applications of Astaxanthin in the Treatment of Ocular Diseases: Emerging Insights
Giannaccare G, Pellegrini M, Senni C, et al. (2020). Marine Drugs / PMCBDOI - Effect of astaxanthin supplementation on cycling performance, muscle damage biomarkers and oxidative stress in young adults: a randomized controlled trial
Res PT, Cermak NM, Stinkens R, et al. (2025). PMC / European Journal of Sport ScienceAPMID:40615903 - Effects of Astaxanthin supplementation on selected metabolic parameters, anthropometric indices, Sirtuin1 and TNF-α levels in patients with coronary artery disease: A randomized, double-blind, placebo-controlled clinical trial
Heidari M, Chaboksafar M, Alizadeh M, et al. (2023). Frontiers in NutritionADOI
Community Sources
Storage
Unopened
Store in a cool, dry, light-protected location; room temperature (below 25 °C).
Opened
Keep container tightly closed; avoid moisture and direct sunlight.
Notes
As a lipid-soluble carotenoid, astaxanthin is susceptible to oxidation by light and heat. Opaque packaging is preferred.